S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 40 of 41

Issue Date	Title / Author(s) / Citation	File
2001-05	Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF Im, SA; Kim, JS; Gomez-Manzano, C; Fueyo, J; Liu, TJ; Cho, MS; Seong, CM; Lee, SN; Hong, YK; Yung, WKA British Journal of Cancer, Vol.84 No.9, pp.1252-1257	DOI
2001-08	Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer Kim, HK; Park, IA; Heo, DS; Noh, DY; Choe, KJ; Bang, YJ; Kim, NK European Journal of Surgical Oncology, Vol.27 No.5, pp.464-471	DOI
2001-10	DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway Wang, SC; Makino, K; Xia, WY; Kim, JS; Im, SA; Peng, H; Mok, SC; Singletary, SE; Hung, MC Oncogene, Vol.20 No.47, pp.6960-6964	DOI
2005-08	Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): Phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor Im, Seock-Ah; Kim, Sung-Bae; Lee, Moon Hee; Im, Young-Hyuck; Lee, Kyung Gee; Song, Hong-Suk; Lee, Myung-Ah; Lee, Junglim; Lee, Nam-Su; Ham, Hae Sun; Kim, Tae-You; Park, Yeon Hee; Lee, Kyung Eun; Kim, Kee Won; Seo, Jae Hong; Lee, Soon Nam; Hong, Young Seon; Bang, Yung-Jue; Kim, Woo-Kun; Park, Hee-Sook Oncology Reports, Vol.14 No.2, pp.481-487	DOI
2006-09	Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells Lee, Keun-Wook; Kim, Jee Hyun; Park, Jung-Hyun; Kim, Hwang-Phill; Song, Sang-Hyun; Kim, Sang Gyun; Kim, Tai Young; Jong, Hyun-Soon; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Noe Kyeong; Bang, Yung-Jue Anticancer Research, Vol.26 No.5A, pp.3429-3438
2007-01	Health-related quality of life in disease-free survivors of breast cancer with the general population Ahn, S. H.; Park, B. W.; Noh, D. Y.; Nam, S. J.; Lee, E. S.; Lee, M. K.; Kim, S. H.; Lee, K. M.; Park, S. M.; Yun, Y. H. ANNALS OF ONCOLOGY Vol.18 No.1, pp. 173-182	DOI
2007-11	Negative impact of heat exposure on cosmesis after conservative treatment for breast cancer Chie, Eui Kyu; Kim, Kyubo; Noh, Dong-Young; Choe, Kuk Jin; Kim, Tae-You; Im, Seok-Ah; Bang, Yung-Jue; Ha, Sung W. Tumori, Vol.93 No.6, pp.591-596	DOI
2008-03	Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Lee, Keun Seok; Chung, Hyun Cheol; Im, Seock Ah; Park, Yeon Hee; Kim, Chul Soo; Kim, Sung-Bae; Rha, Sun Young; Lee, Min Young; Ro, Jungsil Breast Cancer Research and Treatment, Vol.108 No.2, pp.241-250	DOI
2009-04	Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment Moon, H. -G.; Han, W.; Lee, J. W.; Ko, E.; Kim, E. -K.; Yu, J. -H.; Kang, S. Y.; Moon, W. K.; Cho, N.; Park, I. -A.; Oh, D. -Y.; Han, S. -W.; Im, S. -A.; Noh, D. -Y. Annals of Oncology, Vol.20 No.4, pp.636-641	DOI
2009-09	Results of breast-conserving therapy for multifocal or multicentric breast cancers Chie, Eui Kyu; Kim, Kyubo; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Asia-Pacific Journal of Clinical Oncology, Vol.5 No.3, pp.200-205	DOI
2010-01	The sequencing of chemotherapy and radiotherapy in breast cancer patients after mastectomy Kim, Hak Jae; Kim, Jae-Sung; Chie, Eui Kyu; Noh, Dong-young; Bang, Yung-jue; Ha, Sung Whan Tumori, Vol.96 No.1, pp.28-33	DOI
2010-02	Prognostic Factors Affecting the Outcome of Salvage Radiotherapy for Isolated Locoregional Recurrence After Mastectomy Kim, Kyubo; Chie, Eui Kyu; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. American Journal of Clinical Oncology, Vol.33 No.1, pp.23-27	DOI
2010-06	Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy Yhim, Ho-Young; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Im, Seock-Ah; Kim, Tae-You; Kim, Young Tae; Noh, Dong-Young; Chie, Eui Kyu; Ha, Sung Whan; Park, In Ae; Bang, Yung-Jue Cancer, Vol.116 No.12, pp.2890-2901	DOI
2011-01	Age < 40 Years is an Independent Prognostic Factor Predicting Inferior Overall Survival in Patients Treated with Breast Conservative Therapy Kim, Kyubo; Chie, Eui Kyu; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Breast Journal, Vol.17 No.1, pp.75-78	DOI
2011-05	Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab Chang, Hye Jung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Jeon, Yoon Kyung; Park, In Ae; Han, Wonshick; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You Japanese Journal of Clinical Oncology, Vol.41 No.5, pp.593-599	DOI
2011-10	Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Koh, Youngil; Han, Sae-Won; Oh, Do-Youn; Cho, Nariya; Kim, Jee Hyun; Han, Wonshik; Kang, Keon Wook; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Chung, June-Key; Bang, Yung-Jue BMC Cancer, Vol.11, p. 452	DOI
2012-03	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells Kim, Hye Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Anti-Cancer Drugs, Vol.23 No.3, pp.288-297	DOI
2013-01	Breast Cancer Molecular Phenotype and the Use of HER2-Targeted Agents Influence the Accuracy of Breast MRI After Neoadjuvant Chemotherapy Moon, Hyeong-Gon; Han, Wonshik; Ahn, Soo Kyung; Cho, Nariya; Moon, Woo Kyung; Im, Seock-Ah; Park, In Ae; Noh, Dong-Young Annals of Surgery, Vol.257 No.1, pp.133-137	DOI
2013-03	Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study Chow, Louis W. C.; Tung, Stewart Y.; Ng, Ting-Ying; Im, Seock-Ah; Lee, Min-Hyuk; Yip, Adrian Y. S.; Toi, Masakazu; Glueck, Stefan Expert Opinion on Investigational Drugs, Vol.22 No.3, pp.299-307	DOI
2013-12	Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines Ku, Ja-Lok; Park, Sung-Chan; Kim, Kyung-Hee; Jeon, You-Kyung; Kim, Sung-Hee; Shin, Young-Kyoung; Noh, Dong-Young; Im, Seock-Ah; Bang, Yung-Jue; Han, Wonshik; Kim, Woo Ho; Park, Jae-Gahb International Journal of Oncology, Vol.43 No.6, pp.2073-2081	DOI
2015-01	ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Ham, Hye Seon; Lee, Kyung Hun; Kim, Tae Yong; Kim, Yu Jung; Oh, Do-Youn; Kim, Jee Hyun; Han, Wonshik; Jang, In-Jin; Kim, Tae-You; Park, In Ae; Noh, Dong Young Cancer Science, Vol.106 No.1, pp.86-93	DOI
2016-05	Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer Seo, An Na; Lee, Hee Jin; Kim, Eun Joo; Jang, Min Hye; Kim, Yu Jung; Kim, Jee Hyun; Kim, Sung-Won; Ryu, Han Suk; Park, In Ae; Im, Seock-Ah; Gong, Gyungyub; Jung, Kyung Hae; Kim, Hee Jeong; Park, So Yeon British Journal of Cancer, Vol.114 No.10, pp.1109-1116	DOI
2016-10	Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer Jung, Dooyoung; Lee, Kwang-Min; Kim, Won-Hyoung; Lee, Joo-Young; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Spiegel, David; Hahm, Bong-Jin Psychosomatic Medicine, Vol.78 No.8, pp.959-965	DOI
2017-01	Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells Kim, Hee-Jun; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Lee, Kyung Hun; Lau, Alan; Lee, Miso; Kim, Seongyeong; Yang, Yaewon; Kim, Jungeun; Kim, Tae Yong; Oh, Do-Youn; Brown, Jeffrey; O'Connor, Mark J.; Bang, Yung-Jue International Journal of Cancer, Vol.140 No.1, pp.109-119	DOI
2017-04	First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors Bang, Y. J.; Giaccone, G.; Im, S. A.; Oh, D. Y.; Bauer, T. M.; Nordstrom, J. L.; Li, H.; Chichili, G. R.; Moore, P. A.; Hong, S.; Stewart, S. J.; Baughman, J. E.; Lechleider, R. J.; Burris, H. A. Annals of Oncology, Vol.28 No.4, pp.855-861	DOI
2017-12	Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline Sohn, Byeong Seok; Kim, Sung-Bae; Ahn, Jin-Hee; Jung, Kyung Hae; Kim, Jeongeun; Lee, Keun Seok; Ro, Jungsil; Im, Seock Ah; Im, Young-Hyuck; Song, Hong Suk; Park, Hee Sook; Chung, Hyun-Cheol Asia-Pacific Journal of Clinical Oncology, Vol.13 No.6, pp.365-371	DOI
2018-12	A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial Park, Yeon Hee; Lee, Kyung-Hun; Sohn, Joo Hyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee-Hyun; Lee, Ki Hyeong; Ahn, Jin Seok; Kim, Tae-Yong; Kim, Gun Min; Park, In Hae; Kim, Sung-Bae; Kim, Se Hyun; Han, Hye Sook; Im, Young-Hyuck; Ahn, Jin-Hee; Kim, Jung-Yong; Kang, Jahoon; Im, Seock-Ah International Journal of Cancer, Vol.143 No.12, pp.3240-3247	DOI
2019-04	OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer Robson, M. E.; Tung, N.; Conte, P.; Im, S. -A.; Senkus, E.; Xu, B.; Masuda, N.; Delaloge, S.; Li, W.; Armstrong, A.; Wu, W.; Goessl, C.; Runswick, S.; Domchek, S. M. Annals of Oncology, Vol.30 No.4, pp.558-566	DOI
2020-04	Validating the ACOSOG Z0011 trial result: A population-based study using the SEER database Jung, Jiwoong; Kim, Byoung Hyuck; Kim, Jongjin; Oh, Sohee; Kim, Su-jin; Lim, Chang-Sup; Choi, In Sil; Hwang, Ki-Tae Cancers, Vol.12 No.4, p. 950	DOI
2020-07	The 21-gene recurrence score assay and prediction of chemotherapy benefit: A propensity score-matched analysis of the seer database Choi, In Sil; Jung, Jiwoong; Kim, Byoung Hyuck; Oh, Sohee; Kim, Jongjin; Park, Jin Hyun; Park, Jeong Hwan; Hwang, Ki-Tae Cancers, Vol.12 No.7, pp.1829-11	DOI
2021-01	STAT3 Stabilizes IKK alpha Protein through Direct Interaction in Transformed and Cancerous Human Breast Epithelial Cells Hahn, Young-Il; Saeidi, Soma; Kim, Su-Jung; Park, Se-Young; Song, Na-Young; Zheng, Jie; Kim, Do-Hee; Lee, Han-Byoel; Han, Wonshik; Noh, Dong-Young; Na, Hye-Kyung; Surh, Young-Joon Cancers, Vol.13 No.1, pp.1-15	DOI
2021-03	15-Deoxy-Δ12,14-prostaglandin J2 Upregulates VEGF Expression via NRF2 and Heme Oxygenase-1 in Human Breast Cancer Cells Kim, Eun-Hee; Kim, Su-Jung; Na, Hye-Kyung; Han, Wonshik; Kim, Nam-Jung; Suh, Young-Ger; Surh, Young-Joon Cells, Vol.10 No.3, pp.526-24	DOI
2021-06	Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2- advanced breast cancer: MONARCH 2 & 3 trials Toi, Masakazu; Inoue, Kenichi; Masuda, Norikazu; Iwata, Hiroji; Sohn, Joohyuk; Hae Park, In; Im, Seock-Ah; Chen, Shin-Cheh; Enatsu, Sotaro; Turner, P. Kellie; Andre, Valerie A. M.; Hardebeck, Molly C.; Sakaguchi, Sachi; Goetz, Matthew P.; Sledge, George W., Jr. Cancer Science, Vol.112 No.6, pp.2381-2392	DOI
2021-10	Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11) Cho, E. H.; Kim, J. -Y.; Im, S. -A.; Jung, K. H.; Sohn, J.; Lee, K. S.; Chae, Y. S.; Lee, K. H.; Kim, J. H.; Jang, J. -H.; Ahn, J. H.; Park, M. S.; Lee, S. -Y.; Park, Y. H. Esmo Open, Vol.6 No.5, p. 100236	DOI
2022-03	Psychiatric symptoms mediate the effect of resilience on health-related quality of life in patients with breast cancer: Longitudinal examination Lee, Sungwon; Jung, Saim; Jung, Sanghyup; Moon, Jung Yoon; Oh, Gyu Han; Yeom, Chan-Woo; Son, Kyung-Lak; Lee, Kwang-Min; Kim, Won-Hyoung; Jung, Dooyoung; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Shim, Eun-Jung; Hahm, Bong-Jin Psycho-Oncology, Vol.31 No.3, pp.470-477	DOI
2022-08	Do posttraumatic stress symptoms predict trajectories of sleep disturbance and fatigue in patients with breast cancer? A parallel-process latent growth model Shim, Eun-Jung; Jeong, Donghee; Jung, Dooyoung; Kim, Tae-Yong; Lee, Kyung-Hun; Im, Seock-Ah; Hahm, Bong-Jin Psycho-Oncology, Vol.31 No.8, pp.1-8	DOI
2022-12	Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Geyer, C.E.; Garber, J.E.; Gelber, R.D.; Yothers, G.; Taboada, M.; Ross, L.; Rastogi, P.; Cui, K.; Arahmani, A.; Aktan, G.; Armstrong, A.C.; Arnedos, M.; Balmana, J.; Bergh, J.; Bliss, J.; Delaloge, S.; Domchek, S.M.; Eisen, A.; Elsafy, F.; Fein, L.E.; Fielding, A.; Ford, J.M.; Friedman, S.; Gelmon, K.A.; Gianni, L.; Gnant, M.; Hollingsworth, S.J.; Im, S.-A.; Jager, A.; Johannsson, O.Th.; Lakhani, S.R.; Janni, W.; Linderholm, B.; Liu, T.-W.; Loman, N.; Korde, L.; Loibl, S.; Lucas, P.C.; Marme, F.; Martínez de Dueñas, Eduardo; McConnell, R.; Phillips, K.-A.; Piccart, M.; Rossi, G.; Schmutzler, R.; Senkus, Elżbieta; Shao, Z.; Sharma, P.; Singer, C.F.; Spanic, T.; Stickeler, E.; Toi, M.; Traina, T.A.; Viale, G.; Zoppoli, G.; Park, Y.H.; Yerushalmi, R.; Yang, H.; Pang, D.; Jung, K.H.; Mailliez, A.; Fan, Z.; Tennevet, Isabelle; Zhang, J.; Nagy, T.; Sonke, G.S.; Sun, Q.; Parton, M.; Colleoni, M.A.; Schmidt, M.; Brufsky, A.M.; Razaq, Wajeeha; Kaufman, B.; Cameron, D.; Campbell, C.; Tutt, A.N.J.; the OlympiA Clinical Trial Steering Committee and Investigators; Im, Seock-Ah Annals of Oncology, Vol.33 No.12, pp.1250-1268	DOI
2022-12	Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment Kim, Jinyong; Chang, Euijin; Park, Song Yi; Lee, Dae-Won; Kang, Chang Kyung; Choe, Pyoeng Gyun; Kim, Nam Joong; Oh, Myoung-Don; Park, Wan Beom; Lee, Kyung-Hun; Im, Seock-Ah Oncologist, Vol.27 No.12, pp.e931-e937	DOI
2023-06	A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer Lee, Han-Byoel; Lee, Kyung-Hun; Song, Seok Hyun; Kim, Kyubo; Kim, Hong Kyu; Moon, Hyeong-Gon; Han, Wonshik; Lee, Dae-Won; Im, Seock-Ah; Jang, Bum-Sup; Kim, Yong Bae; Yu, Jonghan; Kim, Jee Hyun; Park, Yeon Hee; Shin, Kyung Hwan; Chang, Ji Hyun Oncologist, Vol.28 No.12, pp.1-10	DOI
2023-07	IFI16/Ifi202 released from breast cancer induces secretion of inflammatory cytokines from macrophages and promotes tumor growth Lim, Ga Young; Cho, Sun Wook; Ka, Na-Lee; Lee, Kyung-Hun; Im, Seock-Ah; Kim, Seung-Su; Hwang, Sewon; Lee, Mi-Ock Journal of Cellular Physiology, Vol.238 No.7, pp.1507-1519	DOI

1 2